Search the Newsreel

Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E

MiMedx Group (Nasdaq: MDXG) posts Q2 loss, plans $350M Sanara acquisition

MiMedx Group reported sharply weaker Q2 2026 results with a net loss of $14.84 million, a significant drop from a prior-year profit, primarily due to a 61.1% decline in Wound revenue following Medicare reimbursement changes. Despite a 15.1% increase in Surgical revenue, overall net …

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MIMEDX (Nasdaq: MDXG) announced its second quarter 2026 operating and financial results, reporting net sales of $64 million, a 35% decrease year-over-year, largely due to Medicare reimbursement changes impacting its Wound business. Despite a strong 15% growth in its Surgical franchise, the company posted …

Archimedes Tech SPAC Partners II Ord Shs (ATII) Technical Analysis

This article provides a technical analysis of Archimedes Tech SPAC Partners II Ord Shs (ATII), focusing on various technical indicators and moving averages. It details indicator values and their corresponding buy, sell, or neutral signals, along with an overall summary for both indicators and …

MIMEDX GROUP, INC. Q2 2026: Revenue $64.36M, EPS ($0.1) — 10-Q Summary

MIMEDX GROUP, INC. (MDXG) reported second-quarter 2026 results, showing a significant decline in revenue and a net loss, primarily due to Medicare reimbursement changes and reduced wound-product sales. Revenue fell to $64.36M from $98.61M year-over-year, leading to a diluted EPS of ($0.1). The company …

CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

CalciMedica announced FDA alignment on the Phase 2b trial design for Auxora in acute pancreatitis (AP), identifying new-onset severe respiratory failure as the primary endpoint. The FDA also agreed on evaluating elevated lactate dehydrogenase (LDH) as a potential biomarker to identify high-risk patients. This …

MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Meets Expectations

MiMedx earnings missed by $0.03, revenue topped estimates

MiMedx to buy Sanara MedTech (Nasdaq: SMTI) in $350 million cash-stock deal

ImpediMed (ASX:IPD) Raises Capital to Fund SOZO Platform Growth

IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of IRadimed Corp (IRMD), noting its current financial score is 9.60, ranking it 2nd in the Healthcare Equipment & Supplies industry. It highlights the company's robust financial status and high operating efficiency, with a recent quarterly revenue …

BlackRock (IRMD holder) discloses 5.01% IRADIMED CORP stake on Schedule 13G

BlackRock, Inc. has disclosed a passive ownership stake of 5.01% in IRADIMED CORP (IRMD) common stock, as reported on a Schedule 13G filing. As of June 30, 2026, BlackRock beneficially owned 641,128 shares, with sole voting power over 622,925 shares and sole dispositive power …

Bodhi Tree Multimedia Ltd. Revenue Breakdown – NSE:BTML

Forge Nano Deal Filing Has Not Yet Been Declared Effective

Archimedes Tech SPAC Partners II Co. (NASDAQ: ATII) announced an amendment to its Form S-4 Registration Statement was filed with the SEC on July 24, 2026, regarding its proposed business combination with Forge Nano. This filing includes a preliminary proxy statement/prospectus, which has not …

Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside

CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health overview of CalciMedica Inc (CALC), focusing on its profitability and balance sheet analysis. As of the close on July 27, 2026, the company's stock was trading at $0.708, experiencing a 6.78% drop. The content highlights key financial data …

Form 4 Archimedes Tech SPAC Partners II Co For: 27 July By Investing.com

This article reports on a Form 4 filing for Archimedes Tech SPAC Partners II Co on July 27. It appears to be a very brief announcement, with the core information being the date of the filing. The article provides little to no further details …

Archimedes Tech SPAC Partners II Co. Revenue Breakdown – NASDAQ:ATII

This page provides financial information and an overview for Archimedes Tech SPAC Partners II Co. (ATII) on the NASDAQ stock market. It highlights that the market is currently closed with no trades, and offers various tools and data including fundamentals, statistics, and segment performance.

Archimedes Tech SPAC Partners II Files Amended S-4 Registration for Forge Nano Merger with SEC

Archimedes Tech SPAC Partners II Co. (NASDAQ: ATII) has filed an amended S-4 registration statement with the SEC on July 24, 2026, related to its proposed merger with Forge Nano, Inc. This filing, which includes a preliminary proxy statement and prospectus, is a crucial …

Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline

Riverwater Partners, an investment management company, released its "Micro Opportunities Strategy" Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the Russell Microcap Index, despite a positive absolute result. The benchmark …

CalciMedica Inc (CALC) Institutional Confidence

This article provides details on the institutional confidence in CalciMedica Inc (CALC), listing key shareholders and their respective shareholdings. The data includes the number of shares held by entities like Sanderling Ventures and Alafi Capital Company, as well as changes in their holdings. The …

MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access

MiniMed Group, Inc. (MMED) announced that its MiniMed Flex system, an app-controlled insulin pump, is now covered by Medicare and Medicare Advantage in the U.S., expanding access for diabetes patients. This move is expected to bolster MMED's market presence and revenue opportunities by increasing …

IRMD|IRadimed Corp|Price:94.860|Chg%:+0.370

This article provides a comprehensive stock analysis of IRadimed Corp (IRMD) by TradingKey, highlighting its strong fundamentals, high growth potential, and institutional confidence. The company specializes in MRI-compatible medical devices, with revenue growth averaging 27.84% annually over the last three years and high dividend …

Can IradiMed Extend Its Earnings Momentum In Q2 2026, Will Device Sales Continue To Climb?

(RTTNews) - IRADIMED CORPORATION (IRMD), a medical device company, announced Friday that it will release its results for the second quarter of fiscal 2026 before the market opens on July 31, 2026. The company's management will host a conference call at 11:00 a.m. ET …

CalciMedica Inc (CALC) Cash Flow

This article provides a detailed cash flow statement for CalciMedica Inc (CALC), including operating, investing, and financing cash flows presented quarterly. It highlights key financial figures such as net income from continuing operations, capital expenditures, and free cash flow for various fiscal quarters. The …

IRadimed Corp (IRMD) Stock Price Live, Chart & News - TradingKey

IRadimed Corp (IRMD) is currently trading at $92.495, up 1.41%. The company specializes in MRI-compatible medical devices, including IV infusion pumps and vital signs monitors. Analysts rate IRMD as a "Buy" with a target price of $118.00, indicating a 29.37% upside.

MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of MiMedx Group Inc's (MDXG) stock performance, market capitalization, and P/E ratio. It specifically notes that the company has not distributed any dividends over the past five years. The page indicates financial and corporate information for MDXG available on …

CalciMedica, Inc. Revenue Breakdown – NASDAQ:CALC

This article provides a basic overview of CalciMedica, Inc. (NASDAQ:CALC) financials, specifically referencing its revenue breakdown section on TradingView. It indicates that the company's financial data, including segments and regional performance, is available for review, though the specific breakdown content is not included in …

Archimedes Tech SPAC Partners II Ord Shs (ATII) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Archimedes Tech SPAC Partners II Ord Shs (ATII), listing major shareholders and their proportions. It also breaks down shareholder types and provides institutional shareholding data over several quarters. Key shareholders include Archimedes Tech SPAC Sponsors II L.L.C., …

IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), segmenting its revenue by business and by region. The data, updated on April 6, analyzes contributions from MRI-compatible IV infusion pumps, patient vital signs monitoring systems, disposables, extended warranty amortization, and ferro magnetic …

IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for IRadimed Corp (IRMD), detailing interim and final cash dividends with their respective record, payment, and ex-dividend dates. Over the past five years, IRadimed Corp has distributed a total of 39.46 million USD in dividends. …

IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of IRadimed Corp (IRMD), outlining major individual and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding trends over time, and notable shareholder activity including changes in positions. The report also lists several ETFs that hold …

MiMedx Group Inc (MDXG) Cash Flow

This article provides a detailed cash flow statement for MiMedx Group Inc (MDXG), covering quarterly and annual data up to FY2026Q1. It breaks down various cash flow components including operating, investing, and financing activities, along with changes in working capital and specific asset transactions. …

MiniMed Group, Inc. Revenue Breakdown – NASDAQ:MMED

MiniMed Group, Inc. (NASDAQ: MMED) generated $3.10 billion USD in total revenue last year. Its top-performing segment, Continuous Glucose Monitoring, contributed $1.55 billion USD. The "Rest of World" region was the largest contributor to revenue, accounting for $2.19 billion USD.

TradingKey

This article provides a detailed financial overview of CalciMedica Inc (CALC), focusing on its quarterly and annual income statements. It presents a comprehensive table of income statement metrics from FY2020Q3 to FY2026Q1, including operating expenses, R&D expenses, operating profit, net income, and EPS. The …

ATII|Archimedes Tech SPAC Partners II Ord Shs|Price:10.710|Chg%:+0.030

This article provides a detailed company profile for Archimedes Tech SPAC Partners II Ord Shs (ATII), including its current stock price of $10.710, a slight increase of 0.28%. It lists key financial data such as a market cap of $316.91 million and a P/E …